Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

While some practices remain controversial or speculative, biohackers are united by a shared curiosity: how can we engineer ...

Colossal Biosciences expands its de-extinction mission by acquiring Viagen, the world leader in animal cloning and species ...

The Global Point-of-Care Molecular Diagnostics Market is projected to grow at a CAGR of 10.2% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals ...

Learn why research that continues to look for new substrate alternatives is essential to the future of growing.

A mission to search for the origin-of-life on Titan, Saturn's largest moon, will be aided by University of Otago – Ōtākou ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...

Colossal Biosciences, the world's de-extinction company, today announced its acquisition of Viagen Pets and Equine, the global leader and expert in animal cloning. Viagen provides genetic preservation ...